{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:37Z","timestamp":1788386017656,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several observational studies have revealed an association between autoimmune diseases (AIDs) and colorectal cancer (CRC), although their causal association remained controversial. Therefore, our study used a two-sample Mendelian randomization (MR) analysis to verify the causal association between AIDs and CRC. We employed three common MR approaches, including inverse variance weighted (IVW), weighted median, and MR-Egger methods, to assess the causal association between type 1 diabetes (T1D), systemic lupus erythematosus, rheumatoid arthritis, psoriasis, multiple sclerosis, juvenile idiopathic arthritis, celiac disease, and primary sclerosing cholangitis (PSC) and CRC. The reverse MR analysis was performed to assess the possibility of reverse causation. To evaluate the validity of the analysis, we also performed sensitivity analysis, such as the heterogeneity test, the horizontal pleiotropy test, and the leave-one-out sensitivity analysis, and validated the results in the validation cohort. Our results showed that genetically predicted T1D was nominally associated with a lower risk of CRC (IVW OR\u2009=\u20090.965, 95% CI\u2009=\u20090.939\u20130.992, <jats:italic>P<\/jats:italic>\u2009=\u20090.012). However, genetic susceptibility to psoriasis nominally increased the risk of CRC (IVW OR\u2009=\u20091.026, 95% CI\u2009=\u20091.002\u20131.050, <jats:italic>P<\/jats:italic>\u2009=\u20090.037). Genetically predicted PSC had a significant causal effect on the increasing risk of CRC (IVW OR\u2009=\u20091.038, 95% CI\u2009=\u20091.016\u20131.060, <jats:italic>P<\/jats:italic>\u2009=\u20095.85\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>). Furthermore, the MR analysis between PSC and the CRC validation cohort indicated consistent results. We found no causal association between genetically predicted other five AIDs and CRC (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The results of reverse MR analysis showed that genetically predicted CRC had no causal effect on T1D, psoriasis, and PSC (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The sensitivity analysis demonstrated that the results of the MR analysis were reliable. Our findings help to understand the causal association between AIDs and CRC, which deserves further investigation.<\/jats:p>","DOI":"10.1038\/s41598-024-51903-0","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T06:01:51Z","timestamp":1705557711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring potential causal associations between autoimmune diseases and colorectal cancer using bidirectional Mendelian randomization"],"prefix":"10.1038","volume":"14","author":[{"given":"Lu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"51903_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer. J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer. J. Clin."},{"key":"51903_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M. & Wallace, M. B. Colorectal cancer. Lancet 394, 1467\u20131480 (2019).","journal-title":"Lancet"},{"key":"51903_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","volume":"22","author":"F Baidoun","year":"2021","unstructured":"Baidoun, F. et al. Colorectal cancer epidemiology: Recent trends and impact on outcomes. Curr. Drug Targets 22, 998\u20131009 (2021).","journal-title":"Curr. Drug Targets"},{"key":"51903_CR4","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2174\/0929867327666201026143757","volume":"28","author":"R Kumar","year":"2021","unstructured":"Kumar, R., Harilal, S., Carradori, S. & Mathew, B. A. Comprehensive overview of colon cancer\u2014A grim reaper of the 21st century. Curr. Med. Chem. 28, 2657\u20132696 (2021).","journal-title":"Curr. Med. Chem."},{"key":"51903_CR5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fimmu.2020.01526","volume":"11","author":"I Sieminska","year":"2020","unstructured":"Sieminska, I. & Baran, J. Myeloid-derived suppressor cells in colorectal cancer. Front. Immunol. 11, 1526 (2020).","journal-title":"Front. Immunol."},{"key":"51903_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.06.001","volume":"64","author":"M Yasunaga","year":"2020","unstructured":"Yasunaga, M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin. Cancer Biol. 64, 1\u201312 (2020).","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"51903_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1253\/circj.CJ-19-0705","volume":"84","author":"M Gawa\u0142ko","year":"2020","unstructured":"Gawa\u0142ko, M. et al. Cardiac arrhythmias in autoimmune diseases. Circ. J. 84(5), 685\u2013694 (2020).","journal-title":"Circ. J."},{"key":"51903_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744396","volume":"12","author":"K Glover","year":"2021","unstructured":"Glover, K., Mishra, D. & Singh, T. R. R. Epidemiology of ocular manifestations in autoimmune disease. Front. Immunol. 12, 744396 (2021).","journal-title":"Front. Immunol."},{"key":"51903_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/aje\/kwv292","volume":"183","author":"NR Rose","year":"2016","unstructured":"Rose, N. R. Prediction and prevention of autoimmune disease in the 21st century: A review and preview. Am. J. Epidemiol. 183, 403\u2013406 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"51903_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.autrev.2019.06.009","volume":"18","author":"F Cao","year":"2019","unstructured":"Cao, F. et al. P2X7 receptor: A potential therapeutic target for autoimmune diseases. Autoimmun. Rev. 18, 767\u2013777 (2019).","journal-title":"Autoimmun. Rev."},{"key":"51903_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11033-022-07939-4","volume":"50","author":"X Bai","year":"2023","unstructured":"Bai, X. et al. Progress in the relationship between P2X7R and colorectal cancer. Mol. Biol. Rep. 50, 1687\u20131699 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"51903_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","volume":"395","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n, O. et al. Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study. Lancet 395, 123\u2013131 (2020).","journal-title":"Lancet"},{"key":"51903_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","volume":"5","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n, O. et al. Colorectal cancer in Crohn\u2019s disease: A Scandinavian population-based cohort study. Lancet Gastroenterol. Hepatol. 5, 475\u2013484 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"51903_CR14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"138","author":"J Terzi\u0107","year":"2010","unstructured":"Terzi\u0107, J., Grivennikov, S., Karin, E. & Karin, M. Inflammation and colon cancer. Gastroenterology 138, 2101-2114.e5 (2010).","journal-title":"Gastroenterology"},{"key":"51903_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jaad.2020.09.050","volume":"85","author":"Y Fu","year":"2021","unstructured":"Fu, Y., Lee, C. H. & Chi, C. C. Association of psoriasis with colorectal cancer. J. Am. Acad. Dermatol. 85, 1429\u20131436 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"51903_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/jjco\/hyy047","volume":"48","author":"MF Sona","year":"2018","unstructured":"Sona, M. F., Myung, S. K., Park, K. & Jargalsaikhan, G. Type 1 diabetes mellitus and risk of cancer: A meta-analysis of observational studies. Jpn. J. Clin. Oncol. 48, 426\u2013433 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"51903_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","volume":"15","author":"AL B\u00e5ve","year":"2021","unstructured":"B\u00e5ve, A. L. et al. Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatol. Int. 15, 1174\u20131182 (2021).","journal-title":"Hepatol. Int."},{"key":"51903_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/1346-8138.16644","volume":"50","author":"T Watanabe","year":"2023","unstructured":"Watanabe, T. et al. Risks of malignancies among patients with psoriasis: A cohort study of 360 patients. J. Dermatol. 50, 615\u2013621 (2023).","journal-title":"J. Dermatol."},{"key":"51903_CR19","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51903_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Small, D. S. & Thompson, S. G. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 26, 2333\u20132355 (2017).","journal-title":"Stat. Methods Med. Res."},{"key":"51903_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synth. Methods 10, 486\u2013496 (2019).","journal-title":"Res. Synth. Methods"},{"key":"51903_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","volume":"16","author":"DM Evans","year":"2015","unstructured":"Evans, D. M. & Smith, G. D. Mendelian randomization: New applications in the coming age of hypothesis-free causality. Annu. Rev. Genom. Hum. Genet. 16, 327\u2013350 (2015).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"51903_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou, J. et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594, 398\u2013402 (2021).","journal-title":"Nature"},{"key":"51903_CR24","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464 (2015).","journal-title":"Nat. Genet."},{"key":"51903_CR25","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-022-01213-w","volume":"54","author":"K Ishigaki","year":"2022","unstructured":"Ishigaki, K. et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat. Genet. 54, 1640\u20131651 (2022).","journal-title":"Nat. Genet."},{"key":"51903_CR26","volume":"3","author":"PE Stuart","year":"2022","unstructured":"Stuart, P. E. et al. Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide. HGG Adv. 3, 100069 (2022).","journal-title":"HGG Adv."},{"key":"51903_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).","journal-title":"Science"},{"key":"51903_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2020-218481","volume":"80","author":"E L\u00f3pez-Isac","year":"2021","unstructured":"L\u00f3pez-Isac, E. et al. Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms. Ann. Rheum. Dis. 80, 321\u2013328 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"51903_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193\u20131201 (2011).","journal-title":"Nat. Genet."},{"key":"51903_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji, S. G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269\u2013273 (2017).","journal-title":"Nat. Genet."},{"key":"51903_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41588-022-01222-9","volume":"55","author":"C Fernandez-Rozadilla","year":"2023","unstructured":"Fernandez-Rozadilla, C. et al. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat. Genet. 55, 89\u201399 (2023).","journal-title":"Nat. Genet."},{"key":"51903_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41416-022-02053-5","volume":"128","author":"MC Conroy","year":"2023","unstructured":"Conroy, M. C. et al. UK Biobank: A globally important resource for cancer research. Br. J. Cancer 128, 519\u2013527 (2023).","journal-title":"Br. J. Cancer"},{"key":"51903_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29293-x","volume":"8","author":"X Zhu","year":"2018","unstructured":"Zhu, X. et al. Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer. Sci. Rep. 8, 11814 (2018).","journal-title":"Sci. Rep."},{"key":"51903_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.coph.2012.07.010","volume":"12","author":"RJ Jacobs","year":"2012","unstructured":"Jacobs, R. J., Voorneveld, P. W., Kodach, L. L. & Hardwick, J. C. Cholesterol metabolism and colorectal cancers. Curr. Opin. Pharmacol. 12, 690\u2013695 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"51903_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess, S. et al. Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543\u2013552 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"51903_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Smith, G. D., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"51903_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Smith, G. D. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"51903_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"51903_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2337\/dc14-1996","volume":"38","author":"JL Harding","year":"2015","unstructured":"Harding, J. L., Shaw, J. E., Peeters, A., Cartensen, B. & Magliano, D. J. Cancer risk among people with type 1 and type 2 diabetes: Disentangling true associations, detection bias, and reverse causation. Diabetes Care 38, 264\u2013270 (2015).","journal-title":"Diabetes Care"},{"key":"51903_CR40","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/carcin\/bgn040","volume":"29","author":"MJ Sinnamon","year":"2008","unstructured":"Sinnamon, M. J. et al. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29, 880\u2013886 (2008).","journal-title":"Carcinogenesis"},{"key":"51903_CR41","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1007\/s00125-015-3734-1","volume":"58","author":"L Martino","year":"2015","unstructured":"Martino, L. et al. Mast cells infiltrate pancreatic islets in human type 1 diabetes. Diabetologia 58, 2554\u20132562 (2015).","journal-title":"Diabetologia"},{"key":"51903_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0896-8411(03)00097-0","volume":"21","author":"E Melanitou","year":"2003","unstructured":"Melanitou, E., Fain, P. & Eisenbarth, G. S. Genetics of type 1A (immune mediated) diabetes. J. Autoimmun. 21, 93\u201398 (2003).","journal-title":"J. Autoimmun."},{"key":"51903_CR43","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00262-020-02571-2","volume":"69","author":"MR Dunne","year":"2020","unstructured":"Dunne, M. R. et al. Characterising the prognostic potential of HLA-DR during colorectal cancer development. Cancer Immunol. Immunother. 69, 1577\u20131588 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"51903_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746998","volume":"12","author":"Q Xu","year":"2022","unstructured":"Xu, Q. et al. Causal relationship between gut microbiota and autoimmune diseases: A two-sample mendelian randomization study. Front. Immunol. 12, 746998 (2022).","journal-title":"Front. Immunol."},{"key":"51903_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277155","volume":"18","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition. PLoS\u00a0One 18, e0277155 (2023).","journal-title":"PLoS\u00a0One"},{"key":"51903_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-030-62658-7_9","volume":"1302","author":"M Mart\u00ednez-Rodr\u00edguez","year":"2021","unstructured":"Mart\u00ednez-Rodr\u00edguez, M. & Monteagudo, C. CCL27 signaling in the tumor microenvironment. Adv. Exp. Med. Biol. 1302, 113\u2013132 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"51903_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0001-7310(14)70017-1","volume":"105","author":"SJ Blake","year":"2014","unstructured":"Blake, S. J. & Teng, M. W. Role of IL-17 and IL-22 in autoimmunity and cancer. Actas. Dermosifiliogr. 105, 41\u201350 (2014).","journal-title":"Actas. Dermosifiliogr."},{"key":"51903_CR48","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3390\/cells10092349","volume":"10","author":"CJ Chang","year":"2021","unstructured":"Chang, C. J. et al. Compositional features of distinct microbiota base on serum extracellular vesicle metagenomics analysis in moderate to severe psoriasis patients. Cells 10, 2349 (2021).","journal-title":"Cells"},{"key":"51903_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","volume":"41","author":"M Ala","year":"2022","unstructured":"Ala, M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int. Rev. Immunol. 41, 326\u2013345 (2022).","journal-title":"Int. Rev. Immunol."},{"key":"51903_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101203","volume":"48","author":"X You","year":"2021","unstructured":"You, X. et al. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling. Mol. Metab. 48, 101203 (2021).","journal-title":"Mol. Metab."},{"key":"51903_CR51","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1002\/ibd.22938","volume":"18","author":"K Boonstra","year":"2012","unstructured":"Boonstra, K. et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm. Bowel Dis. 18, 2270\u20132276 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"51903_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus, E. V. Jr. et al. PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54, 91\u201396 (2005).","journal-title":"Gut"},{"key":"51903_CR53","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","volume":"29","author":"DG Shaw","year":"2023","unstructured":"Shaw, D. G. et al. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat. Med. 29, 1520\u20131529 (2023).","journal-title":"Nat. Med."},{"key":"51903_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492\u2013503 (2019).","journal-title":"Nat. Microbiol."},{"key":"51903_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","volume":"69","author":"S Lemoinne","year":"2020","unstructured":"Lemoinne, S. et al. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 69, 92\u2013102 (2020).","journal-title":"Gut"},{"key":"51903_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41385-020-00347-6","volume":"14","author":"RY Gao","year":"2021","unstructured":"Gao, R. Y. et al. Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis. Mucosal Immunol. 14, 479\u2013490 (2021).","journal-title":"Mucosal Immunol."},{"key":"51903_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","volume":"20","author":"L Song","year":"2018","unstructured":"Song, L. et al. The risks of cancer development in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis. Arthritis Res. Ther. 20, 270 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"51903_CR58","first-page":"91","volume":"83","author":"J Lasa","year":"2018","unstructured":"Lasa, J., Rausch, A. & Zubiaurre, I. Risk of colorectal adenomas in patients with celiac disease: A systematic review and meta-analysis. Rev. Gastroenterol. Mex. (Engl Ed) 83, 91\u201397 (2018).","journal-title":"Rev. Gastroenterol. Mex. (Engl Ed)"},{"key":"51903_CR59","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1212\/WNL.0000000000011219","volume":"96","author":"RA Marrie","year":"2021","unstructured":"Marrie, R. A. et al. Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study. Neurology 96, e501\u2013e512 (2021).","journal-title":"Neurology"},{"key":"51903_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C. & Suissa, S. Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Res. Ther. 17, 212 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"51903_CR61","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/ene.15226","volume":"29","author":"P Bosco-L\u00e9vy","year":"2022","unstructured":"Bosco-L\u00e9vy, P. et al. Incidence and risk of cancer among multiple sclerosis patients: A matched population-based cohort study. Eur. J. Neurol. 29, 1091\u20131099 (2022).","journal-title":"Eur. J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51903-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T06:04:48Z","timestamp":1705557888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51903-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-51903-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"22 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1557"}}